ONWARD: Reigniting Hope to Reclaim Movement

[Norm]

Neurosurgeon Jocelyne Bloch, MD, and Scott Chesney discuss neurostimulation for spinal cord injury

https://youtu.be/EhaG0XJXM3k via @YouTube

[French]

https://www.biospace.com/article/rel...l-cord-injury/

[Mitchitsu]

Do we finally have a company that's going to be dedicated and follow through with therapies that get tested and breakthrough access? That would be so unbelievable.

It seems like there's nobody that isn't spinning their wheels and blowing hot air when it comes to the timing and fundraising. It would be great if we finally have this one really getting it done.

[skippopotamus]

I hope ejl10, who is participating in the epidural stimulation trial for his hands, will give us an update.

[lunasicc42]

I hope ejl10, who is participating in the epidural stimulation trial for his hands, will give us an update.

I thought he said before that sadly it wasn't working at the time, perhaps it was too early. Any update ejl10

[Norm]

ONWARD Medical's ARC-EX granted FDA Breakthrough Device Designation


https://www.med-technews.com/news/me...e-designation/

[Barrington314mx]

"ONWARD is now preparing regulatory submissions for the U.S. and Europe, with the expectation that this therapy may be approved for commercialisation in late 2023."

That's a pretty big deal!

[ejl10]

Hello everyone, my apologies for not posting sooner any information on my experience. Sadly, over the course of the trial, I didn’t recover any function. However, I heard, promising rumors that it worked better for other people. Not much more I can say! Glad to see that research is progressing.

[LethalSpoon]

Some news in the mail,

ONWARD Up-LIFT Pivotal Study Results Shared at the 2023 American Academy of Neurology Annual Meeting

This week at the American Academy of Neurology 2023 Annual Meeting in Boston, Dr. Jim Guest, MD, PhD and Clinical Professor, Department of Neurological Surgery for The Miami Project to Cure Paralysis, presented more detailed Up-LIFT study results, sharing from the podium that the study met all primary safety and effectiveness endpoints.

Up-LIFT is the first global pivotal study to evaluate the effect of non-invasive spinal cord stimulation on strength and function of the hands and arms after spinal cord injury (SCI).

Dr. Guest also noted that 72% of study participants responded to ARC-EX Therapy*, defined as showing clinically and statistically significant improvement in at least one pre-selected strength and at least one pre-selected functional performance outcome. This is an important finding given the historical lack of effective therapies for people with chronic spinal cord injuries.

We are pleased to share these important additional study results conveyed by Dr. Guest, and we expect more Up-LIFT study data to be made available in the coming months when the study manuscript is published.

ONWARD is committed to developing therapies to address unmet medical needs for people with SCI. We are working hard to make ARC-EX Therapy broadly available, targeting FDA submission later this year.

Please join me in thanking the many therapists, clinicians, and people with spinal cord injury who contributed to this landmark study.


Warm regards,

Dave Marver
CEO

[skippopotamus]

This is a questionnaire from Onward on what return is important to us. They’re gathering market data which seems like progress to me.
https://form.jotform.com/230811113127340

[Norm]

ONWARD Schedules Webcast to Provide First Quarter Business Update
https://www.investorsobserver.com/ne...99096874859598


To join the webcast via Zoom, please register using this link .

The webcast will be held on May 16, 2023, at 2:00PM CET / 08:00AM ET. It will be hosted by CEO Dave Marver and CFO Lara Smith Weber, who will discuss highlights from the first quarter and provide a business update.

[Norm]

ONWARD Announces First-in-Human Use of ARC-IM™ Lead to Restore Movement and Function after Spinal Cord Injury https://finance.yahoo.com/news/onward-announces-first-human-arc-153000649.html?soc_src=social-sh&soc_trk=tw&tsrc=twt via @YahooFinance